Navigation Links
PharmD in Medical News

Diplomat Specialty Pharmacy Promotes Rinku A. Patel, PharmD to Vice President, Pharmacy Strategy

SWARTZ CREEK, Mich., June 2 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced the promotion of Dr. Rinku A. Patel to Vice President, Pharmacy Strategy. Patel was previously Diplomat's Director of Pharmacy Development and Operations. Patel's new role will encompass 3 main areas: ...

Actress and Mom Alison Sweeney Teams Up With the American Pharmacists Association to Help Fellow Allergy Sufferers Find Relief This Spring

...encourage sufferers who have questions about nasal congestion products or how to access these products to ask their pharmacist," said Michael Negrete, pharmd of the American Pharmacists Association. "Many people are unaware that some of the oral decongestant medicines they have relied on for years are still...

Prime Pharmacists Recognized by the Journal of Managed Care Pharmacy

...s clinical pharmacists, Patrick Gleason, PharmD, FCCP, BCPS, Cathy Starner, pharmd and Jeremy Schafer, pharmd were awarded the Journal of Managed Care Pharmacy (JMCP) Award of Excellenc...

Clearing the 'fog'

...kill the tumor, not if they cause a cognitive deficiency, like memory loss." Walker and Raffa decided to fill that void. Two years ago, Walker and pharmd student John Foley, set out to see if certain chemotherapeutic agents caused memory and learning deficits in mice. They tested two older drugs commonl...

CuraGen to Present at the Rodman & Renshaw Annual Global Investment Conference

...ragen.com . CRGN-G Contacts: Sean Cassidy Vice President and Chief Financial Officer scassidy@curagen.com (203) 871-4400 Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

CuraGen Reports First Quarter 2008 Financial Results

...ss release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 CURAGEN CORPORATION AND SUBSIDIARY CONDENSE...

Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine

...after 6 months. This study adds to the current literature on the economic value of comprehensive pain programs. Investigators: Julie L. Cunningham, pharmd Mayo Clinic, Rochester, MN 55902 Jeffrey D. Rome Mayo Clinic, Rochester, MN 55905 Cynthia O. Townsend Mayo Clinic, Rochester, MN 55905 Jennifer L. Ker...

CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA

... or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-P Contacts: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 ...

Weight-based dosing of ribavirin improves outcomes for patients with hepatitis C

...e fundamental basis for the impaired responsiveness in this population, they say. In an accompanying editorial, Steven-Huy Han, MD and Jason Smith, pharmd of Los Angeles, report that this study adds significantly to our understanding of interferon therapy in African American patients. It will change the ...
PharmD in Medical Technology

SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts

... on Addictions, University at Buffalo , Buffalo, NY Isabel Burk, MS Director of The Health Network, New York, NY Jeanna M. Marraffa, pharmd Clinical Toxicologist, Upstate New York Poison Center, Assistant Professor, SUNY Upstate Medical University , Syracuse, NY Phil Buckenmeyer,...

CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma

... otherwise. CRGN-P Contacts: Sean Cassidy Vice President and Chief Financial Officer scassidy@curagen.com (203) 871-4400 Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008

...ragen.com . CRGN-F Contacts: Sean Cassidy Vice President and Chief Financial Officer scassidy@curagen.com (203) 871-4400 Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma

...e or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-P Contact: Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE

...rmation, future events or otherwise. Contacts: Sean Cassidy Vice President and Chief Financial Officer scassidy@curagen.com Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 CRGN-F - FINANCIAL TABLES ATTACHED - ...

CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer

...e or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-P Contact: Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma

...s release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contacts: Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 CRGN-P ...

CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma

...ss release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 CRGN-P ...

CuraGen Advances CR011-vcMMAE into Phase II

...ss release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 CRGN-P ...

CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference

...ress release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contacts: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 CRGN-P ...
PharmD in Biological Technology

Premier Research Names Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance

PHILADELPHIA, May 26 /PRNewswire/ -- Premier Research Group Limited, the international pharmaceutical services company, announces the appointment of Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance. In this position, he will lead the global pharmacovigilance team ensuring th...

Diplomat Specialty Pharmacy Hires Rinku A. Patel, PharmD as Director of Pharmacy Development and Operations

SWARTZ CREEK, Mich., Nov. 3 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced that Dr. Rinku A. Patel has joined the company's executive management team. Dr. Patel will serve as Director of Pharmacy Development and Operations. She will be responsible for the management and developmen...

L&M Healthcare Communications, LLC, Hires Scott Karasinski, PharmD

Scott Karasinski, PharmD to Run Medical Services Department of the Expanding Independent Medical Education Agency MOUNTAINSIDE, N.J., Feb. 5 /PRNewswire/ -- L&M Healthcare Communications announces the appointment of Scott Karasinski, PharmD to the position of Vice President, Sci...

EPI-Q, Inc. Expands Capabilities with Addition of Anthony Vita, MD, MPH and Peter Herout, PharmD

OAK BROOK, Ill., Nov. 5 /PRNewswire/ -- EPI-Q, Inc., a consulting firm providing outcomes research and health economics services to the global biopharmaceutical and healthcare industries, announces the addition of Anthony J. Vita, MD, MPH and Peter Herout, PharmD to their team of clinical prof...

CuraGen Sells Ownership of Belinostat to TopoTarget A/S

... or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-P Contacts: Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

Major Medical Journal Reports Higher Success, Fewer Complications and Lower Cost Treating DVT With Trellis(R) Isolated Thrombolysis Compared With Catheter-Directed Thrombolysis

...me required for follow-up monitoring in a costly critical care unit compared with CDT patients. The study, which was authored by Daniel E. Hilleman, pharmd (Department of Pharmacy Practice, Creighton University School of Pharmacy, Omaha, NE) and Mahmood K. Razavi, MD (Department of Vascular and Interventi...

CuraGen to Present at the BIO CEO & Investor Conference

...orporation is headquartered in Branford, Connecticut. For additional information please visit http://www.curagen.com . Contacts: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 CRGN-G ...

CuraGen Reports Fourth Quarter and Year End 2007 Financial Results

... release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 CURAGEN CORPORATION AND SUBSIDIARY CONDE...

CuraGen Corporation Receives Notification from NASDAQ

... or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-F Contacts: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 ...

CuraGen Corporation Announces Appointment of Sean Cassidy as CFO

... or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-G Contacts: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 ...
Other Tags
(Date:10/2/2014)... interact with stress to trigger heart disease in some people, ... about 13 percent of people, but only in those who ... heart disease risk through simple measures such as exercise, ... said. The study authors analyzed genetic data from nearly ... the EBF1 gene and higher levels of central obesity, as ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. 1, ... the stops to rescue surgical patients in crisis are ... such heroism is questionable, a new study suggests. ... saving elderly patients with life-threatening complications after major surgery, ... senior author Dr. Amir Ghaferi. He is assistant professor ...
(Date:10/1/2014)... team of scientists has shown that more than 80 ... existing drugs. , The study found that medicines called ... a genetic mutation that is present in more than ... are currently used, or are in clinical trials, for ... disorders. , Bowel cancer is the second-most common cancer ...
(Date:10/1/2014)... BOSTON (October 1, 2014) Despite a policy ... with developmental disabilities, this vulnerable population continues to ... of The Journal of the American Dental ... Medicine and Tufts University School of Dental Medicine ... factors influencing at-home oral care provided by caregivers ...
(Date:10/1/2014)... October 01, 2014 Bedros Keuilian is ... Boot Camp fitness boot camps, he’s also considered the ... , with sold out business summits, a line of ... consultant to a recent Spike TV reality show to ... now is the time for personal trainers and fitness ...
Breaking Medicine News(10 mins):Health News:Genes May Make Some More Prone to Heart Disease When Under Stress 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 3Health News:Eighty percent of bowel cancers halted with existing medicines 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3
(Date:10/1/2014)... researchers hope to take a healthy salad up a ... of breast cancer in leafy greens. , "In the ... either by eating the salad or making a pill ... of biomedical engineering at Case Western Reserve School of ... G. Komen breast cancer organization is funding the research ...
(Date:10/1/2014)... 2014 Novel detection technology ... field  The life science field has ... the years. Some are shooting stars and others ... novel detection technology that has raised much enthusiasm ... technology is becoming commercially available. With their unique ...
(Date:9/30/2014)... the Mediterranean each year, but its deep-blue waters ... Almost 1,000 alien species, including fish, crustaceans, and ... human activities. In the open-access journal Frontiers ... researchers analyzed data from a new information system ... the introduction of alien species has changed the ...
Breaking Biology News(10 mins):Scientists wield plant viruses against deadly human disease 2Scientists wield plant viruses against deadly human disease 3First-of-a-kind Solution for Utilizing Photon Upconversion 2Biodiversity in the Mediterranean is threatened by alien species 2
Other Contents